王罡

Curriculum Vitae

PERSONAL INFORMATION

Name: Gang Wang                         

Gender: Male                                

Citizenship: Canadian

PROFESSIONAL QUALIFICATIONS

Royal College of Physicians and Surgeons of Canada in Anatomic Pathology, 2016

Fellow of the Royal College of Physicians of Canada, 2016  

EDUCATION: 

Institution and location

Degree

Year

Field of study

University of British Columbia, Vancouver, Canada  

Ph.D.

2009

Pathology

Tongji Medical University, Wuhan, China     

M.Surg.

2002

Surgery

Tongji Medical University, Wuhan, China     

MD           

1997

Clinical Medicine     

PROFESSIONAL EXPERIENCE:

07/2017 to present

Consultant Pathologist

BC Cancer Agency, Vancouver, Canada

07/2016 to 06/2017

GU Pathology Fellowship

MD Anderson Cancer Center, USA

09/2015 to 05/2016

Cytopathology Mini Fellowship

BC Cancer Agency, University of BC, Canada

07/2013 to 06/2016

Anatomic Pathology Resident

University of British Columbia, Canada

07/2012 to 06/2013

Anatomic Pathology Resident

University Hospitals, CWRU, USA

07/2010 to 06/2011

Clinical Trainee (Pathology)

University of British Columbia, Canada

07/2001 to 09/2002

Chief Resident

Tongji Hospital, China

09/1999 to 09/2002

Resident Surgeon

Tongji Hospital, China

07/1997 to 06/1999

Resident Surgeon

Wuhan Central Hospital,   China

07/1995 to 06/1997

Internship

Union Hospital, Tongji Medical Univ., China

RESEARCH EXPERIENCE:

06/2011 to 06/2012

Postdoctoral fellow

Heart & Lung Institute, University of BC, Canada

11/2009 to 05/2010

Postdoctoral fellow

Fred Hutchinson Cancer Research Center, USA

01/2009 to 09/2009

Postdoctoral fellow

BC Cancer Agency, University of BC, Canada

01/2003 to 01/2009

PhD student

BC Cancer Agency, University of BC, Canada

HONORS AND AWARDS:

Mentored   Trainee Award, MD Anderson Cancer Center

2016

UBC   Department of Pathology Resident Research Grant

2014, 2015

Delegate,   College of American Pathologists Resident Forum

2013

CWRU   Department of Pathology Resident Research Grant

2013

Stipend   Award, International Society of Urological Pathology

2013

British   Columbia Lung Association Karl K. Pump Fellowship

2011-2012

Department   of Defense (USA) Research Fellowship

2010-2012

Michael   Smith Foundation for Health Research Trainee Award

2007-2009

Research   Highlight, UroToday.com

2009

Research   Highlight, Prostate Cancer and Prostate Disease

2007

University   of BC Graduate Fellowship, UBC

2005-2007

Poster   Award, BCCA Annual Cancer Conference

2005

Ph.D.   Tuition Fee Award, UBC

2004-2008

Faculty   of Graduate Studies International Graduate Tuition Scholarship, UBC

2003-2004

Outstanding   Graduate Student Award, Tongji Medical University

2001

Graduate   Students Fellowship, Tongji Medical University

2000-2001

Outstanding   Undergraduate Student Award, Tongji Medical University

1995

Undergraduate   Students Fellowship, Tongji Medical University

1993-1997

Subject   Scholarship, Tongji Medical University

1993

Excellent   Report of Social Practice Award, Tongji Medical University

1993

 

PUBLICATIONS:

Wang,G., Black,P.C., Goebell,P.J., Roshen,S., Ji,L., Cordon-Cardo,C., Cote,R., Sauter,G., Waldman,F., Dinney,C. Prognostic Markers in pT3 Bladder Cancer: A Study from International Bladder Cancer Tissue Microarray Project. Journal of Urology. 2018 in preparation

Chu,J., Wang,G., Zhou,C. Diagnostic Value of Voided Urine for Bladder Carcinoma. Diagnostic Cytopathology. 2018 Submitted

Nira,G., Horb,S., Fazlia,L., Skinniderc,B., Tavassolic,P., Turbind,D., Villamilc,C., Wang,G., Wilson,R.S., Iczkowski,K.A., Lucia,M.S., Black,P., Karimi,D., Abolmaesumi,P., Goldenberg,S.L., Salcudean,S.E. Automatic Grading of Prostate Cancer in Digitized Histopathology Images: Learning from Multiple Experts. Medical Image Analysis. 2018 Submitted

Zhang,X., Su,M.W., Cheng,Y., Martinka,M., Wang,G., Huang,Y., Li,L., Graziano,L., Lei,Y., Zhou,Y. Lysyl Oxidase-Like 3 promotes melanoma growth and invasion in vitro, but has dual effects on melanoma patient survival. Cancer Research. 2018 Submitted

Wang,G., Li,Q., Zhou,C. Primary Bronchial Epithelial Myoepithelial Carcinoma with Thyroid Transcription Factor-1 Expression – A Diagnostic Pitfall in Small Biopsies. Diagnostic Pathology. 2018 Submitted

Wang,G. McKenney,J.K. Urinary Bladder Pathology: WHO Classification and AJCC Staging Update. Archives of Pathology & Laboratory Medicine. 2018 In press

Wang,G., Li, X., Zhang,M., Czerniak,B., Guo,C.C. Small Cell Carcinoma of the Urinary Bladder - A Clinicopathologic Analysis of 81 Cases. American Journal of Surgical Pathology. 2018 Submitted

Wang,G., Rao,P. Succinate dehydrogenase deficient renal cell carcinoma. Archives of Pathology & Laboratory Medicine. 2018 In press

MacAulay,C., Keyes,M., Hayes,M., Lo,A., Wang,G., Guillaud,M., Gleave,M., Fazil,L., Korbelik,J., Collins,C., Keyes,S., Palcic,B. Quantification of Large Scale DNA Organization for Predicting Prostate Cancer Recurrence. Cytometry: Part A. 2017 [Epub ahead of print]

Wang,G., Huang,H., Kamat,A.M, Siefker-Radtke,A., Dinney,C.P., Troncoso,P., Czerniak,B., Guo,C.C. High-Grade Neuroendocrine Carcinoma in Urachal Adenocarcinoma - Report of 3 Cases. Human Pathology 2017;67:126-133

Myung,J.K., Wang,G., Chiu,H.L., Wang,J., Mawji,N.R., Sadar, M.D. Inhibition of Androgen Receptor by Decoy Molecules Delays Progression to Castration-recurrent Prostate Cancer. PLoS ONE. 2017 E12(3):e0174134

Wang,G., Hyrcza,M., van der Westhuizen,N., Pringle,K., Salina.D. Proximal epithelioid sarcoma following a history of malignant melanoma -- A diagnostic challenge. Cytopathology. 2017;28(4):329-332

Wang,G., Black,P.C., Skinnider,B.F., Hayes,M.M., Jones,E.C. Post-radiation Epithelioid Angiosarcoma of the Urinary Bladder and Prostate: Case Report and Literature Review. Canadian Urological Association Journal. 2016;10(5-6): E197-E200

Wang,G., Bashir.J., Chiu.W., Tang.J., Toma.M., Virani.S.A., Seidman.M.A. Cardiac Sarcoidosis. Canadian Journal of Pathology. 2016;8-4:38

Wang,G., Tucker,T., Ng,T., Villamil,CF., Hayes,M.. Fine Needle Aspiration of Soft Tissue Myoepithelioma. Diagnostic Cytopathology. 2016;44(2):152-5

Wang,G., Bordeaux,J.S., Rowe,D.J., Honda,K.S. Lymphoepithelioma-like Carcinoma of the Skin, A Report of Two Cases and Review of Literature. JAMA  Dermatology. 2014;150(12):1367-8

Andersen,R.J., Mawji,N.R., Wang,J. Wang,G., Hile,S., Myung,J.K., Watt,K., Tam,T., Yang,Y.C., Bañuelos,C.A., Williams,D.E., McEwan,I., Wang,Y.Z. and Sadar,M.D. Regression of castrate-recurrent prostate cancer by a small molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell .2010;17(6):535-546

Romanuik,T.L., Wang,G., Morozova,O., Delaney,A., Marra,M.A. and Sadar,M.D. LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Medical Genomics. 2010;3:43

Wang,G., Hile,S., Comuzzi,B., Tien,A., Wang,J., Yong,T.M.K., Jelescu-Bodos,A., Blaszczyk,N., Vessella,R.L., Masri,B.A., Sadar,M.D. Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression. Cancer Research. 2009;69(8):3433-3442

Romanuik,T.L., Wang,G., Holt,R.A., Jones,S.JM., Marra,M.A. and Sadar,M.D. Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries. BMC Genomics. 2009;15(10):476-494

Wang,G., Wang,J., Sadar,M.D. Crosstalk between the androgen receptor and β-catenin in androgen-independent prostate cancer. Cancer Research. 2008;68(23):9918-9927

Wang,G., Jones,S., Marra,M., Sadar,M.D. Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells. Oncogene. 2006 ;25(55):7311-7323

Wang,G., Sadar,M.D. Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer. J Cell Biochem. 2006;98(1):36-53

Chen,W.M., Wang,G., Ling,X., Xie,C.S. UDS test of the nano-beta-tricalcium phosphate/collagen artificial bone. J Clin Stomatol. 2003;19(10):593-4

Ling,X., Chen,W.M., Liu,S., Wang,G. Expression of TGF-beta in region of bone defect repaired by collagen/nano-beta-tricalcium phosphate composite artificial bone. J Huazhong Univ Sci Tech Med Sci. 2003;23(3):302-5

Ling,X., Tao,X.J., Chen,W.M., Liu,S., Wang,G. Expression of TGF-beta in Region of Bone Defect Repaired by Collagen/nano-beta-tricalcium Phosphate Composite Artificial Bone. J Clin Stomatol. 2003;19(10):595-7

Ma,J.Z., Guo,S.L., Wang,G., Yu,W.H. Green or Desensitizer in the Treatment of Dentine Hypersensitiveness: a Report of 40 Cases. Med Guide. 2003;22(2):97-8

Chen,W.M., Lin,W.J., Wang,G. Verben Injection in the Treatment of Flat Lichen: a Report of 56 Cases. Med Guide. 2003;22(2):99-100

Wang,G., Chen,W.M., Wu,Y.T., Ling,X. Ames test of the nano-beta-tricalcium phosphate/collagen artificial bone. J Clin Stomatol. 2003;19(1):17-9

Wang,G., Chen,W.M. The Nano Drug Delivery System and Tumors.  Foreign Medical Sciences. 2002;29(2):71-3

Ling,X., Chen,W.M., Wang,G. Experimental Study of Composite Artificial Bone of Collagen/nano-beta-tricalcium Phosphate Conducting Subperiosteal Bone Formation. J Huazhong Univ Sci Tech Health Sci. 2002;31(6):700-2

Ling,X., Yin,Y.X, Wang,H.J, Wang,G. The Effect of Auto-solidified Soft Lining Material to the Chewing Efficiency of False Teeth. J Huazhong Univ Sci Tech Health Sci. 2001;30(6):623-4

Chen,W.M., Tao,X.J., Ma,J.Z., Wang,G. Clinical Observation of Gingival Hyperplasia Caused by Nifedipine. J Clin Stomatol. 2001;17(4):284-5

 

CONFERENCE PODIUM PRESENTATIONS:

Wang,G. Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic Analysis of 81 Cases. United States & Canadian Academy of Pathology (USCAP) Annual Meeting, San Antonio, TX, USA. March 4-10, 2017

Wang,G. Proximal epithelioid sarcoma following a history of malignant melanoma -- A diagnostic challenge. Pathology Research Day, University of British Columbia, Vancouver, B.C. Canada. May 22, 2015

Wang,G. Pathology of Antibody Mediated Rejection in Heart Transplantation. Morbidity & Mortality Conference. Department of Medicine, Case Western Reserve University. April 12, 2013

Wang,G. Gene expression signature of CaP bone metastasis. PNW Prostate Cancer SPORE Retreat, Vancouver, BC, Canada. July 10, 2009

Wang,G. Identification of pathways involved in the hormonal progression of prostate cancer. World Microarray Congress, Vancouver, BC, Canada. June 29-30, 2007

Wang,G. Affymetrix GeneChip Analysis of Androgen Regulated Genes in Prostate Cancer LNCaP Cell. Pathology Research Day, University of British Columbia, Vancouver, B.C. Canada. May 27, 2005

Wang,G. The Collagen/nano-beta-tricalcium Phosphate Artificial Bone. Hubei Province Annual Stomatology Conference, Wuhan, Hubei, China. April 16, 2002

 

ABSTRACTS:

Hruska,C., Wang,G., Tamboli,P., Petros,F.G., Wood,C.G, Matin,S.F., Zhang,M. Local Tumor Recurrence Following Partial Nephrectomy. United States & Canadian Academy of Pathology (USCAP) Annual Meeting, Vancouver, BC, Canada. March 17-23, 2018

Wang,G., Li,X., Zhang,M., Czerniak,B., Guo,C.C., Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic Analysis of 81 Cases. United States & Canadian Academy of Pathology (USCAP) Annual Meeting, San Antonio, TX, USA. March 4-10, 2017

Wang,G., Hyrcza,M., van der Westhuizen,N., Nielsen,T., Salina.D. Proximal epithelioid sarcoma following a history of malignant melanoma -- A diagnostic challenge. Canadian Association of Pathologists (CAP-ACP) Annual Meeting, Montreal, QC, Canada. June 20-24, 2015

Wang,G., Comuzzi,B., Tien,A., Wang,J., Jelescu-Bodos,A., Blaszczyk,N., Masri,B.A., and Sadar,M.D. Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression. Annual Cancer Conference of BC Cancer Agency, Vancouver, B.C. Canada. November 20-22, 2008

Wang,G., Wang,J., Sadar,M.D. Androgen Receptor Negatively Regulates the Expression of SESN1, a Potential Tumor Suppressor. American Urological Association Annual Conference. Orlando, FL, USA. May 17-22, 2008

Wang,G., Wang,J., Sadar,M.D. Androgen Receptor Negatively Regulates the Expression of SESN1, a Potential Tumor Suppressor. Keystone Symposia--- Nuclear Receptors: Steroid Sisters. Whistler, BC, Canada. March 30 - April 4, 2008

Wang,G., Wang,J., Sadar,M.D. Androgen Receptor Negatively Regulates the Expression of SESN1, a Potential Tumor Suppressor. Annual Cancer Conference of BC Cancer Agency, Vancouver, B.C. Canada. November 29 - December 1, 2007

Wang,G., Jones,S., Marra,M., and Sadar,MD. Genes Targeted by Both the Androgen and PKA Sigalling Pathways That Dependent upon Androgen Receptor. Genome British Columbia Genomics Forum. Vancouver, B.C. Canada. April 7, 2006

Wang,G., Jones,S., Marra,M., and Sadar,MD. Genes Targeted by Both the Androgen and PKA Sigalling Pathways That Dependent upon Androgen Receptor. Keystone Symposia--- Nuclear Receptors: Steroid Sisters. Banff, Alberta, Canada. March 18-23, 2006

Wang,G., Jones,S., Marra,M., and Sadar,MD. Genes Targeted by Both the Androgen and PKA Sigalling Pathways That Dependent upon Androgen Receptor. The 15th Annual Meeting of the Society for Basic Urologic Research, Miami, FL, United States. December 1-4, 2005

Wang,G., Jones,S., Marra,M., and Sadar,MD. Genes Targeted by Both the Androgen and PKA Sigalling Pathways That Dependent upon Androgen Receptor. BCCA Annual Cancer Conference, Vancouver, B.C. Canada. November 3-5, 2005 (Best Presentation Awarded)

Wang,G., Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of Androgen Regulated Genes in Prostate Cancer LNCaP Cell. Pathology Research Day, University of British Columbia, Vancouver, B.C. Canada. May 27, 2005

Wang,G., Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of Androgen Regulated Genes in Prostate Cancer LNCaP Cell. BCCA Annual Cancer Conference, Vancouver, B.C. Canada. November 25-27, 2004

Wang,G., Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of Androgen Regulated Genes in Prostate Cancer LNCaP Cell. Inland Northwest Cancer Conference, Spokane, WA, United States. November 12-13, 2004

Mawji,N.R., Blaszczyk,N., Masri,B., Wang,G., Jones,S., Marra,M., Sadar,M.D. Comparison of the Transcriptome and Proteome of Prostate Cancer Cells Treated with Osteoblast Derived Factors. EMBL 2nd Symposium-Heidelberg, Germany. October 16-19, 2004

Wang,G., Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of the Gene Expression during Progression of Prostate Cancer to Androgen Independence. First Northern Lights Conference, Canadian Federation of Biological Science 47th Annual meeting, Vancouver, B.C. Canada. June 16-20, 2004

Wang,G.,  Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of the Gene Expression during Progression of Prostate Cancer to Androgen Independence. Pathology Research Day, University of British Columbia, Vancouver, B.C. Canada. May 7, 2004

Wang,G.,  Jones,S., Sadar,M.D. Affymetrix GeneChip Analysis of the Gene Expression during Progression of Prostate Cancer to Androgen Independence. BCCA Annual Cancer Conference, Vancouver, B.C. Canada. November 27-29, 2003

 


已举办讲座

我要评论

0条评论